Altman Z-Score

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

With final court approval, Crescita Therapeutics will be delisted from the TSX as global platform ClinActiv snaps up its dermatology assets.

Celebrating a half-century of progress, Liberty Hill Foundation's anniversary gala was an urgent plea to fund the fight for Los Angeles's future.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

A top scientific honor for Dr. Mariano Garcia-Blanco validates a new approach to autoimmune disease, targeting a genetic trait in 50% of the population.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

Facing financial headwinds, Lulus is betting big on wholesale. Can new deals with Amazon and Victoria's Secret secure its future in fashion?

OCI Global nets $172.6M from a major Methanex share sale, a strategic move as both chemical giants face financial pressure and a volatile methanol market.

As private equity giant EIG sells its entire stake, Diversified Energy counters by repurchasing nearly half the shares in a bold vote of confidence.

Inuvo's stock faces uncertainty as a strategic pivot causes a steep Q4 revenue drop, betting its future on its privacy-focused IntentKey AI technology.

As Mike Eastwood retires, new CFO Gary Bischoping, a tech and finance veteran, is set to guide the company's ambitious AI transformation and next chapter of growth.

As Sri Lanka emerges from its economic crisis, a first-of-its-kind European-regulated fund provides a liquid, secure path to its undervalued assets.

NCR Voyix expands its share repurchase program, signaling strong confidence while navigating a major business transformation and a competitive market.

Warner Bros. Discovery pushes for a Netflix merger but opens a one-week window for Paramount Skydance to fix its flawed bid. A bidding war looms.

After a bitter legal battle across Europe, Maxeon and Aiko sign a landmark patent agreement, reshaping the global market for high-efficiency solar tech.

Cabot Corp's purchase of a key Bridgestone facility in Mexico is a strategic play to dominate the reinforcing carbons market and secure vital supply chains.

Onity Group is raising $150 million via high-yield notes, a strategic but risky move to refinance debt and fund growth amid a complex financial backdrop.

With over $260 million in sales, Sphere's 'Wizard of Oz' is more than a show; it's a validation of a new era in high-tech, immersive entertainment.

Roundtable's Web3 model is attracting top media talent and legacy brands, signaling a major disruption for sports content and the creator economy.